Hydroxylamido–amino acid complexes of oxovanadium(v). Toxicological study in cell culture and in a zebrafish model

Abstract

Oxovanadium(V) complexes [VO(NH(2)O)(2)(val)] and [VO(NH(2)O)(2)(met)] caused inhibition of cell proliferation in two osteoblast cell lines, MC3T3-E1 and UMR106, as well as the viability of zebrafish eggs. In MC3T3-E1, both compounds inhibited cell proliferation (up to ca. 40% at 25 μM [VO(NH(2)O)(2)(val)] and 25% at 25 μM [VO(NH(2)O)(2)(met)]). This effect occurs in a dose response manner from 2.5 μM (p < 0.01) with a more deleterious action of [VO(NH(2)O)(2)(met)]. In UMR106 tumoral cells, [VO(NH(2)O)(2)(val)] inhibited cell proliferation up to 75% from 25 μM while [VO(NH(2)O)(2)(met)] behaved as an inhibitory agent in the whole range of concentrations (p < 0.01). Similar toxic effects were obtained from morphological studies in cell cultures. Moreover, the IC(50) values for both complexes in culture studies correlated with the IC(50) values obtained with an in vivo model of toxicity (FET test). Besides, the cytotoxicity evaluation in cell culture showed a decrease in mitochondrial activity which was stronger for [VO(NH(2)O)(2)(met)] than for [VO(NH(2)O)(2)(val)] (44% vs. 58% at 25 μM) in both cell lines (p < 0.001). Genotoxicity assessed by micronuclei induction also showed a stronger effect of [VO(NH(2)O)(2)(met)] in both cell lines. Besides, [VO(NH(2)O)(2)(val)] caused DNA damage determined by comet formation in MC3T3-E1 cells in the range of 2.5-25 μM, while this effect could not be observed in the osteosarcoma cells. On the other hand, [VO(NH(2)O)(2)(val)] enhanced ROS levels over basal up to 225% and 170% at 100 μM in MC3T3-E1 and UMR106 cells, respectively (p < 0.01). For [VO(NH(2)O)(2)(met)] a similar situation was observed, suggesting an important role for oxidative stress in the toxicity mechanism of action. Although both complexes showed interesting results that would deserve further drug development [VO(NH(2)O)(2)(val)] was more stable than [VO(NH(2)O)(2)(met)] in the solid state. Therefore, we consider that [VO(NH(2)O)(2)(val)] is a good candidate to be tested in in vivo models as a potential antitumoral agent.

New heterobimetallic ferrocenyl derivatives are promising antitrypanosomal agents

“…62 In the past, we and other researchers have successfully used this model for studying in vivo toxicity of new prospective metal-based drugs. 63,64 Being [Pt(L3)(dppf)](PF 6 ) the most active and selective compound of the new series, its in vivo toxicity on zebrafish embryos was tested. All zebrafish embryos were alive in the [Pt(L3)(dppf)](PF 6 ) whole concentration range examined (1-100 M) and no apparent toxicity was observed at the endpoint (48 h) of the assays.…”

Mononuclear Pd(ii) and Pt(ii) complexes with an α-N-heterocyclic thiosemicarbazone: cytotoxicity, solution behaviour and interaction versus proven models from biological media

“…Oxidative stress is one of the main factors reported that trigger the deleterious actions of metal-based compounds. 44,45 For a better understanding of the possible mechanism involved in the cytotoxicity of both complexes in cancer cell lines, we evaluated the effect of complexes 1 and 2 on oxidative stress through the oxidation of the probe DHR-123. DHR-123 is a mitochondria-associated probe that selectively reacts with hydrogen peroxide.…”

Characterization and cytotoxic effect of aqua-(2,2′,2′′-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells

“…It has been reported that these compounds, depending on the cellular line, may promote the generation of the reactive oxygen species (ROS) mainly in the mitochondria (Leon et al 2012a, 2014b; Rivadeneira et al 2009; Di Virgilio et al 2011) leading to a decrease of glutathione (GSH) concentration. GSH is one of the mayor reducing agents responsible for maintaining the cellular redox status through the balance of the couple glutathione/glutathione disulphide (GSH/GSSG).…”